Changeflow GovPing Pharma & Drug Safety Tunable Luminescent Organic Salts for Enhanced ...
Routine Rule Added Final

Tunable Luminescent Organic Salts for Enhanced Imaging and Photodynamic Therapy

Favicon for changeflow.com EPO Patent Bulletin - Therapeutics (A61P)
Published
Detected
Email

Summary

EPO granted patent EP3664892A2 to Board of Trustees of Michigan State University covering tunable luminescent organic salts for enhanced medical imaging and photodynamic therapy applications. The invention relates to novel compositions and methods for diagnostic imaging and therapeutic treatment using organic salt compounds. The patent designates all EU member states and select European countries as protected territories.

What changed

EPO granted patent EP3664892A2 to Board of Trustees of Michigan State University for tunable luminescent organic salt compositions designed for enhanced medical imaging and photodynamic therapy. The patent application, filed by inventors Lunt, Lunt, Broadwater, Young, and Bates, claims compositions and methods for diagnostic imaging and therapeutic applications. The designated states include all EU member states plus other European Patent Convention contracting states.

For pharmaceutical and medical device companies developing imaging agents or photodynamic therapy treatments, this patent establishes intellectual property rights that may restrict freedom to operate in this technological space. Companies should conduct freedom-to-operate analyses before commercializing products in this domain within designated territories.

What to do next

  1. Monitor patent portfolio for freedom-to-operate implications if developing imaging or photodynamic therapy products
  2. Review licensing opportunities for luminescent organic salt technology

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY

Publication EP3664892A2 Kind: A2 Apr 01, 2026

Applicants

Board of Trustees of Michigan State University

Inventors

LUNT, Richard R., LUNT, Sophia Y., BROADWATER, Deanna, YOUNG, Margaret, BATES, Matthew

IPC Classifications

A61K 41/00 20200101AFI20210325BHEP A61K 49/00 20060101ALI20210325BHEP A61P 35/00 20060101ALI20210325BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3664892A2

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent licensing Medical imaging Photodynamic therapy
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Compliance frameworks
GxP
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!